特发性颅内压增高

Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010 Aug;28(3):593-617.全文  摘要

Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998 Dec;105(12):2313-7. 摘要

Hayreh SS. Pathogenesis of oedema of the optic disc (papilloedema): a preliminary report. Br J Ophthalmol. 1964 Oct;48:522-43.全文  摘要

Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998 Dec;105(12):2313-7. 摘要

Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985 Mar;5(1):55-6. 摘要

Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982 Jan;45(1):13-8.全文  摘要

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee; Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014 Apr 23-30;311(16):1641-51.全文  摘要

Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010 Jul 7;341:c2701.全文  摘要

Hoffmann J, Mollan SP, Paemeleire K, et al. European Headache Federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018 Oct 8;19(1):93.全文  摘要

1. Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010 Aug;28(3):593-617.全文  摘要

2. Shah VA, Kardon RH, Lee AG, et al. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology. 2008 Feb 19;70(8):634-40. 摘要

3. Ghaffari-Rafi A, Mehdizadeh R, Ko AWK, et al. Idiopathic intracranial hypertension in the United States: demographic and socioeconomic disparities. Front Neurol. 2020 Sep 8;11:869.全文  摘要

4. Mollan SP, Aguiar M, Evison F, et al. The expanding burden of idiopathic intracranial hypertension. Eye (Lond). 2019 Mar;33(3):478-85.全文  摘要

5. Radhakrishnan K, Thacker AK, Bohlaga NH, et al. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci. 1993 May;116(1):18-28. 摘要

6. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol. 1988 Aug;45(8):875-7. 摘要

7. Miah L, Strafford H, Fonferko-Shadrach B, et al. Incidence, prevalence and healthcare outcomes in idiopathic intracranial hypertension: a population study. Neurology. 2021 Jan 20;96(8):e1251-61.全文  摘要

8. Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology. 1999 Mar 10;52(4):870-2. 摘要

9. Sundholm A, Burkill S, Waldenlind E, et al. A national Swedish case-control study investigating incidence and factors associated with idiopathic intracranial hypertension. Cephalalgia. 2021 Dec;41(14):1427-36.全文  摘要

10. Radhakrishnan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993 Jan;50(1):78-80. 摘要

11. Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998 Dec;105(12):2313-7. 摘要

12. Joynt RJ, Sahs AL. Brain swelling of unknown cause. Neurology. 1956 Nov;6(11):801-3. 摘要

13. Wall M, Dollar JD, Sadun AA, et al. Idiopathic intracranial hypertension: lack of histologic evidence for cerebral edema. Arch Neurol. 1995 Feb;52(2):141-5. 摘要

14. Hayreh SS. Pathogenesis of oedema of the optic disc (papilloedema): a preliminary report. Br J Ophthalmol. 1964 Oct;48:522-43.全文  摘要

15. Wall M, White WN 2nd. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci. 1998 Jan;39(1):134-42.全文  摘要

16. Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology. 2011 May 3;76(18):1564-7. 摘要

17. Deonna T, Guignard JP. Acute intracranial hypertension after nalidixic acid administration. Arch Dis Child. 1974 Sep;49(9):743.全文  摘要

18. Mushet GR. Pseudotumor and nitrofurantoin therapy. Arch Neurol. 1977 Apr;34(4):257. 摘要

19. Konomi H, Imai M, Nihei K, et al. Indomethacin causing pseudotumor cerebri in Bartter's syndrome. N Engl J Med. 1978 Apr 13;298(15):855. 摘要

20. Larizza D, Colombo A, Lorini R, et al. Ketoprofen causing pseudotumor cerebri in Bartter's syndrome. N Engl J Med. 1979 Apr 5;300(14):796. 摘要

21. Feldman MH, Schlezinger NS. Benign intracranial hypertension associated with hypervitaminosis A. Arch Neurol. 1970 Jan;22(1):1-7. 摘要

22. Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology. 1984 Nov;34(11):1509-11. 摘要

23. Colucciello M. Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia. Arch Ophthalmol. 2003 Jul;121(7):1064-5. 摘要

24. Van Dop C, Conte FA, Koch TK, et al. Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism. N Engl J Med. 1983 May 5;308(18):1076-80. 摘要

25. Saul RF, Hamburger HA, Selhorst JB. Pseudotumor cerebri secondary to lithium carbonate. JAMA. 1985 May 17;253(19):2869-70. 摘要

26. Shah A, Roberts T, McQueen IN, et al. Danazol and benign intracranial hypertension. Br Med J. 1987 May 23;294(6583):1323.全文  摘要

27. Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol. 1998 Jul;126(1):116-21. 摘要

28. Gardner K, Cox T, Digre KB. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review. Neurology. 1995 Jan;45(1):6-10. 摘要

29. Orme DR, Vegunta S, Miller MA, et al. A comparison between the clinical features of pseudotumor cerebri secondary to tetracyclines and idiopathic intracranial hypertension. Am J Ophthalmol. 2020 Dec;220:177-82. 摘要

30. Thurtell MJ, Trotti LM, Bixler EO, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol. 2013 Jul;260(7):1748-51.全文  摘要

31. NORDIC Idiopathic Intracranial Hypertension Study Group; Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014 Jun;71(6):693-701.全文  摘要

32. Klein A, Dotan G, Kesler A. Familial occurrence of idiopathic intracranial hypertension. Isr Med Assoc J. 2018 Sep;20(9):557-60.全文  摘要

33. Kuehn MH, Mishra R, Deonovic BE, et al. Genetic survey of adult-onset idiopathic intracranial hypertension. J Neuroophthalmol. 2019 Mar;39(1):50-5.全文  摘要

34. Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998 Dec;105(12):2313-7. 摘要

35. Blanch RJ, Vasseneix C, Liczkowski A, et al. Differing presenting features of idiopathic intracranial hypertension in the UK and US. Eye (Lond). 2019 Jun;33(6):1014-9.全文  摘要

36. Keltner JL, Johnson CA, Cello KE, et al. Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci. 2014 Apr 29;55(5):3200-7.全文  摘要

37. Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985 Mar;5(1):55-6. 摘要

38. Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982 Jan;45(1):13-8.全文  摘要

39. Wall M, George D. Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain. 1991 Feb;114 (pt 1A):155-80. 摘要

40. Friedman DI, Quiros PA, Subramanian PS, et al. Headache in idiopathic intracranial hypertension: Findings from the Idiopathic Intracranial Hypertension Treatment Trial. Headache. 2017 Sep;57(8):1195-205. 摘要

41. Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia. 1990 Dec;10(6):331-5. 摘要

42. Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol. 1984 Oct;16(4):489-94. 摘要

43. Wall M, Falardeau J, Fletcher WA, et al. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology. 2015 Sep 1;85(9):799-805. 摘要

44. Meador KJ, Swift TR. Tinnitus from intracranial hypertension. Neurology. 1984 Sep;34(9):1258-61. 摘要

45. Scott CJ, Kardon RH, Lee AG, et al. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010 Jun;128(6):705-11. 摘要

46. Wall M, Thurtell MJ; NORDIC Idiopathic Intracranial Hypertension Study Group. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial. Br J Ophthalmol. 2017 Sep;101(9):1256-60. 摘要

47. Mollan SP, Davies B, Silver NC, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1088-100.全文  摘要

48. Neville L, Egan RA. Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol. 2005 Dec;40(6):775-7. 摘要

49. Lim MJ, Lin JP. The effects of carbon dioxide on measuring cerebral spinal fluid pressure. Childs Nerv Syst. 2009 Jul;25(7):783-4. 摘要

50. Bono F, Quattrone A. CSF opening pressure: reference interval and the effect of body mass index. Neurology. 2007 Apr 24;68(17):1439-40. 摘要

51. Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983 Oct;33(10):1386-8. 摘要

52. Whiteley W, Al-Shahi R, Warlow CP, et al. CSF opening pressure: reference interval and the effect of body mass index. Neurology. 2006 Nov 14;67(9):1690-1. 摘要

53. Berdahl JP, Fleischman D, Zaydlarova J, et al. Body mass index has a linear relationship with cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci. 2012 Mar 15;53(3):1422-7.全文  摘要

54. Avery RA, Shah SS, Licht DJ, et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med. 2010 Aug 26;363(9):891-3.全文  摘要

55. NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee; Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014 Apr 23-30;311(16):1641-51.全文  摘要

56. Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med. 1974 May;133(5):802-7. 摘要

57. Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010 Jul 7;341:c2701.全文  摘要

58. Amaral JF, Tsiaris W, Morgan T, et al. Reversal of benign intracranial hypertension by surgically induced weight loss. Arch Surg. 1987 Aug;122(8):946-9. 摘要

59. Sugerman HJ, Felton WL 3rd, Sismanis A, et al. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999 May;229(5):634-40.全文  摘要

60. Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011 Jan;114(1):34-9. 摘要

61. Friedman DI, Streeten DH. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology. 1998 Apr;50(4):1099-104. 摘要

62. Rubin RC, Henderson ES, Ommaya AK, et al. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg. 1966 Oct;25(4):430-6. 摘要

63. Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017 Sep;57(8):1303-10. 摘要

64. Piper RJ, Kalyvas AV, Young AM, et al. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev. 2015 Aug 7;(8):CD003434.全文  摘要

65. Lubow M, Kuhr L. Pseudotumor cerebri: comments on practical management. In: Glaser JS, Smith JL, eds. Neuro-ophthalmology, Vol. IX. St Louis, MO: CV Mosby; 1976:199-206.

66. Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuroophthalmol. 1988;8:93-8.

67. Lichter PR. Reducing side effects of carbonic anhydrase inhibitors. Ophthalmology. 1981 Mar;88(3):266-9. 摘要

68. Garner LL, Carl EF, Ferwerda JR. Advantages of sustained-release therapy with acetazolamide in glaucoma. Am J Ophthalmol. 1963;55:323-7.

69. Zimran A, Beutler E. Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts? Am J Ophthalmol. 1987 Dec 15;104(6):654-8. 摘要

70. ten Hove MW, Friedman DI, Patel AD, Irrcher I, et al; NORDIC Idiopathic Intracranial Hypertension Study Group. Safety and tolerability of acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuroophthalmol. 2016 Mar;36(1):13-9. 摘要

71. Corbett JJ. The 1982 Silversides lecture: problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci. 1983 Nov;10(4):221-9. 摘要

72. Pollay M, Fullenwider C, Roberts PA, et al. Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg. 1983 Dec;59(6):945-50. 摘要

73. Roberts PA, Pollay M, Engles C, et al. Effect on intracranial pressure of furosemide combined with varying doses and administration rates of mannitol. J Neurosurg. 1987 Mar;66(3):440-6. 摘要

74. Vogh BP, Langham MR Jr. The effect of furosemide and bumetanide on cerebrospinal fluid formation. Brain Res. 1981 Sep 21;221(1):171-83. 摘要

75. Buhrley LE, Reed DJ. The effect of furosemide on sodium-22 uptake into cerebrospinal fluid and brain. Exp Brain Res. 1972 Apr 27;14(5):503-10. 摘要

76. Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994 Apr;9(2):130-4. 摘要

77. Schoeman J, Donald P, van Zyl L, et al. Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev Med Child Neurol. 1991 May;33(5):396-405. 摘要

78. Celebisoy N, Gokcay F, Sirin H, et al. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007 Nov;116(5):322-7. 摘要

79. Hoffmann J, Mollan SP, Paemeleire K, et al. European Headache Federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018 Oct 8;19(1):93.全文  摘要

80. European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013 [internet publication].全文

81. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996 Jun;46(6):1524-30. 摘要

82. Rosenberg M, Smith C, Beck R, et al. The efficacy of shunting procedures in pseudotumor cerebri (abstract). Neurology. 1989;39(suppl 1):S209.

83. Johnston I, Besser M, Morgan MK. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg. 1988 Aug;69(2):195-202. 摘要

84. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997 Sep;49(3):734-9. 摘要

85. McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. 2004 Oct;101(4):627-32. 摘要

86. Sinclair AJ, Kuruvath S, Sen D, et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia. 2011 Dec;31(16):1627-33. 摘要

87. Goh KY, Schatz NJ, Glaser JS. Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol. 1997 Jun;17(2):86-91. 摘要

88. Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1426-9.全文  摘要

89. Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology. 1993 May;100(5):683-90. 摘要

90. Rizzo JF 3rd, Lessell S. Choroidal infarction after optic nerve sheath fenestration. Ophthalmology. 1994 Sep;101(9):1622-6. 摘要

91. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1993 May;111(5):632-5. 摘要

92. Fonseca PL, Rigamonti D, Miller NR, et al. Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol. 2014 Oct;98(10):1360-3. 摘要

93. Huang LC, Winter TW, Herro AM, et al. Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension. J Neuroophthalmol. 2014 Sep;34(3):223-8. 摘要

94. Niotakis G, Grigoratos D, Chandler C, et al. CSF diversion in refractory idiopathic intracranial hypertension: single-centre experience and review of efficacy. Childs Nerv Syst. 2013 Feb;29(2):263-7. 摘要

95. Rizzo JL, Lam KV, Wall M, et al. Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension. J Neuroophthalmol. 2015 Mar;35(1):22-5. 摘要

96. Wall M, Johnson CA, Kutzko KE, et al. Long- and short-term variability of automated perimetry results in patients with optic neuritis and healthy subjects. Arch Ophthalmol. 1998 Jan;116(1):53-61. 摘要

97. Digre KB, Varner MW, Corbett JJ. Pseudotumor cerebri and pregnancy. Neurology. 1984 Jun;34(6):721-9. 摘要

98. Lee AG, Pless M, Falardeau J, et al. The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. Am J Ophthalmol. 2005 May;139(5):855-9. 摘要

99. Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol. 2013 Feb;15(1):1-12.全文  摘要

100. Tang RA, Dorotheo EU, Schiffman JS, et al. Medical and surgical management of idiopathic intracranial hypertension in pregnancy. Curr Neurol Neurosci Rep. 2004 Sep;4(5):398-409. 摘要

101. Karmaniolou I, Petropoulos G, Theodoraki K. Management of idiopathic intracranial hypertension in parturients: anesthetic considerations. Can J Anaesth. 2011 Jul;58(7):650. 摘要

102. Friedman DI. Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol. 2006;26:61-64. 摘要

103. Kabanovski A, Kisilevsky E, Yang Y, et al. Dural venous sinus stenting in the treatment of idiopathic intracranial hypertension: a systematic review and critique of literature. Surv Ophthalmol. 2022 Jan-Feb;67(1):271-87. 摘要

104. Xu W, Prime Z, Papchenko T, et al. Long term outcomes of idiopathic intracranial hypertension: observational study and literature review. Clin Neurol Neurosurg. 2021 Jan 5;205:106463. 摘要

105. Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology. 2009 Jan 27;72(4):304-9.全文  摘要